Alternativas farmacológicas en el manejo de la taquicardia supraventricular

Abstract

Introduction: Supraventricular tachycardia (SVT) is an arrhythmia with a higher incidence in women and older adults, with clinical manifestations ranging from mild to potentially severe. The initial pharmacological treatment of choice includes adenosine, which is highly effective for acute cardioversion. Alternatives such as beta-blockers, calcium channel blockers, and potassium channel blockers are reserved for refractory cases or contraindications. Objective: To describe, based on international management guidelines, the efficacy, adverse effects, contraindications, and pharmacological interactions of adenosine and its alternatives for the treatment of SVT. Methodology: A literature review based on the search, selection, and analysis of updated information was conducted. Clinical studies, international management guidelines, systematic and narrative reviews, as well as reference texts were included. Conclusions: The importance of individualizing the management of SVT according to etiology, clinical severity, and available resources is emphasized to optimizing clinical outcomes.